Copyright
©The Author(s) 2001.
World J Gastroenterol. Feb 15, 2001; 7(1): 42-48
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.42
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.42
Groups | 2g* | 2s* | SSS△ |
Normal control group | 1.00 ± 0.00 | 1.00 ± 0.00 | 0 |
Fibrotic model group | 9.20 ± 5.01 | 10.40 ± 5.06 | 14.60 ± 7.82 |
Colchicine treatment group | 10.40 ± 5.06 | 7.40 ± 4.99a | 10.60 ± 3.34a |
High-dose IFN-γ group | 9.60 ± 3.37 | 3.00 ± 1.05bc | 5.10 ± 2.88bc |
Medium-dose IFN-γ group | 6.00 ± 4.22 | 5.60 ± 4.20bc | 7.70 ± 3.53bc |
Low-dose IFN-γ group | 7.60 ± 4.79 | 5.40 ± 2.32bc | 8.00 ± 3.30bc |
- Citation: Weng HL, Cai WM, Liu RH. Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis. World J Gastroenterol 2001; 7(1): 42-48
- URL: https://www.wjgnet.com/1007-9327/full/v7/i1/42.htm
- DOI: https://dx.doi.org/10.3748/wjg.v7.i1.42